Attending the Inaugral Microbes in Women’s Health Congress
Our Principal Scientist Andrew Lewis and Co-Founder Thang Vo-Ta recently took part in the inaugural Microbes in Women’s Health Congress in Copenhagen! They attended superb seminars/presentations, had great catch-ups and forged new & important connections in the groundbreaking microbiome space. The unfolding science is getting undeniable: reproductive tract dysbiosis or the lack of a healthy …
When Moving Lab Hoods Becomes a Lesson in Startup Resilience
At first glance, these are just a few “bog-standard” laboratory fume hoods & biosafety cabinets that one would expect in the labs of any R&D intensive medtech startup. But the story behind these key pieces of equipment and what they represent goes deeper… Firstly it’s outrageously expensive to build, let alone properly fit-out lab space. …
Attending the Launch of Tommy’s National Centre for Preterm Birth Research
It was wonderful for members of our team to celebrate Tommy’s launch of their amazing new preterm birth centre. Always energising and inspiring to be in a room full of clinicians, researchers, midwives, engineers, supporters, and those with lived experience – for such an important cause. We are excited about how impactful our Callavid device will …
Presenting at the Inclusivity in Women’s Health Tech Event
Congratulations to our colleague Dr Serena de Gelidi and our collaborators at UCL School Of Pharmacy Catherine Tuleu and Scheilly Tsilova on their well received presentation at the Inclusivity in Women’s Health Tech event held at the Royal College of Physicians. We were delighted to share the results of our project “Supporting women needing vaginal progesterone: …
Double Milestone with the Intellectual Property Office UK
Firstly, we’re delighted to announce the first issuance of our patent for our “2nd generation” enhancements to our proprietary drug delivery and administration device, with multiple jurisdictions outstanding. Secondly, we’re proud to unveil the official trademarked name for our groundbreaking vaginal drug delivery device: CALLAVID®. This marks a pivotal moment as we step up our …
Forbes France Spotlights Calla Lily Clinical Care
We’re delighted to see Calla Lily Clinical Care showcased in the latest print edition of Forbes France! This came from being recognised as one of the top startups at the MedFemTech Congress in Paris earlier this year. We’re always grateful for press coverage as it not only highlights our dedication but also elevates awareness around …
Making the 2023 List of 200 Trailblazing Leaders in Women’s Health and FemTech
Congrats to our co-founders Dr. Lara Zibners and Thang Vo-Ta on being named in the annual 200 Trailblazing Leaders in Women’s Health and FemTech. It’s a real who’s who of the influential leaders working to improve the access and quality of healthcare for women worldwide. We’re delighted for the recognition of Lara, Thang and of …
Building our Brand New Offices and Labs
With a well documented critical shortage of lab space throughout London / Cambridge / Oxford, Calla Lily Clinical Care has had to take matters into its own hands! Our new offices and labs have been under construction and we can’t wait to take occupation in our own enhanced workspace. Having unfettered access to our own …
Attending the Medica 2023 Medical Trade Fair
Members of our team attended Medica 2023 in Dusseldorf, the world’s largest medical trade fair. It was great to meet up in person with our existing partners, but also to network and discover new exciting materials, suppliers and to create unique partnering opportunities.
Attending the LSX Investival Showcase
It was a busy start to kick-off Europe’s biggest dedicated healthcare investment week by taking part in the LSX – partnering for Life Science eXecutives Investival Showcase here in London. Always a privilege to be able to share Calla Lily Clinical Care‘s exciting progress with our drug delivery technology and to meet with several new …